you are viewing a single comment's thread.
Any opinions on where this might good with good data presented? I'm assuming + $0.40 would be a given, but this is for a larger patient population so maybe more?
I'll say at least 0.50 if the melanoma data is positive.
Sentiment: Strong Buy